Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Raymond G Watts

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Journal of Pediatric Hematology/Oncology|April 6, 2019
Recurrent Skin Langerhan Cell Histiocytosis Successfully Treated With Indomethacin MonotherapyAditi Dhir, David R Kelly, Raymond G Watts, et al.
Scientific Reports|December 21, 2017
Whole exome sequencing identified sixty-five coding mutations in four neuroblastoma tumorsAubrey L Miller, Patrick L Garcia, Joseph G Pressey, et al.
The New England Journal of Medicine|April 17, 2009
Inhibitors of factor VIII in black patients with hemophiliaKevin R Viel, Afshin Ameri, Thomas C Abshire, et al.
Frontiers in Oncology|January 30, 2018
Pediatric Anaplastic Embryonal Rhabdomyosarcoma: Targeted Therapy Guided by Genetic Analysis and a Patient-Derived Xenograft StudyStuart L Cramer, Aubrey L Miller, Joseph G Pressey, et al.
Plos One|May 14, 2013
Phenotypes of allo- and autoimmune antibody responses to FVIII characterized by surface plasmon resonanceKenneth B Lewis, Richard J Hughes, Melinda S Epstein, et al.
Genes and Immunity|April 22, 2025
A scan of pleiotropic immune mediated disease genes identifies novel determinants of baseline FVIII inhibitor status in hemophilia AMarcio A Almeida, Vincent P Diego, Kevin R Viel, et al.
Genes and Immunity|September 25, 2025
Correction: A scan of pleiotropic immune mediated disease genes identifies novel determinants of baseline FVIII inhibitor status in hemophilia AMarcio A Almeida, Vincent P Diego, Kevin R Viel, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Journal of Pediatric Hematology/Oncology|April 6, 2019
Recurrent Skin Langerhan Cell Histiocytosis Successfully Treated With Indomethacin MonotherapyAditi Dhir, David R Kelly, Raymond G Watts, et al.
Scientific Reports|December 21, 2017
Whole exome sequencing identified sixty-five coding mutations in four neuroblastoma tumorsAubrey L Miller, Patrick L Garcia, Joseph G Pressey, et al.
The New England Journal of Medicine|April 17, 2009
Inhibitors of factor VIII in black patients with hemophiliaKevin R Viel, Afshin Ameri, Thomas C Abshire, et al.
Frontiers in Oncology|January 30, 2018
Pediatric Anaplastic Embryonal Rhabdomyosarcoma: Targeted Therapy Guided by Genetic Analysis and a Patient-Derived Xenograft StudyStuart L Cramer, Aubrey L Miller, Joseph G Pressey, et al.
Plos One|May 14, 2013
Phenotypes of allo- and autoimmune antibody responses to FVIII characterized by surface plasmon resonanceKenneth B Lewis, Richard J Hughes, Melinda S Epstein, et al.
Genes and Immunity|April 22, 2025
A scan of pleiotropic immune mediated disease genes identifies novel determinants of baseline FVIII inhibitor status in hemophilia AMarcio A Almeida, Vincent P Diego, Kevin R Viel, et al.
Genes and Immunity|September 25, 2025
Correction: A scan of pleiotropic immune mediated disease genes identifies novel determinants of baseline FVIII inhibitor status in hemophilia AMarcio A Almeida, Vincent P Diego, Kevin R Viel, et al.
Pageof 2